Jiangsu Province Hospital — Nanjing, Jiangsu

Public research footprint of Jiangsu Province Hospital, compiled from the ClinicalTrials.gov public registry.

646

Registered studies

277

Active

162

Recruiting now

208

Completed

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · Triple Negative Breast Cancer(TNBC) · Acute Respiratory Distress Syndrome (ARDS) · Triple Negative Breast Neoplasms

Recently updated registry entries

NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)
NCT06459180 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… (Active Not Recruiting)
NCT06596473 — A Study of BG-C477 in Participants With Advanced Solid Tumors (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Jiangsu Province Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.